EP1019041A4 - Method of improving disturbed behavior and elevating mood in humans - Google Patents

Method of improving disturbed behavior and elevating mood in humans

Info

Publication number
EP1019041A4
EP1019041A4 EP98920311A EP98920311A EP1019041A4 EP 1019041 A4 EP1019041 A4 EP 1019041A4 EP 98920311 A EP98920311 A EP 98920311A EP 98920311 A EP98920311 A EP 98920311A EP 1019041 A4 EP1019041 A4 EP 1019041A4
Authority
EP
European Patent Office
Prior art keywords
humans
disturbed behavior
improving
elevating mood
mood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98920311A
Other languages
German (de)
French (fr)
Other versions
EP1019041A1 (en
Inventor
Ladislav Volicer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimed Pharmaceuticals LLC
Original Assignee
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/866,511 external-priority patent/US5804592A/en
Application filed by Unimed Pharmaceuticals LLC filed Critical Unimed Pharmaceuticals LLC
Publication of EP1019041A1 publication Critical patent/EP1019041A1/en
Publication of EP1019041A4 publication Critical patent/EP1019041A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
EP98920311A 1997-05-07 1998-05-06 Method of improving disturbed behavior and elevating mood in humans Withdrawn EP1019041A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4581397P 1997-05-07 1997-05-07
US45813P 1997-05-07
US08/866,511 US5804592A (en) 1997-05-30 1997-05-30 Method for improving disturbed behavior and elevating mood in humans
US866511 1997-05-30
PCT/US1998/009269 WO1998050027A1 (en) 1997-05-07 1998-05-06 Method of improving disturbed behavior and elevating mood in humans

Publications (2)

Publication Number Publication Date
EP1019041A1 EP1019041A1 (en) 2000-07-19
EP1019041A4 true EP1019041A4 (en) 2002-04-17

Family

ID=26723227

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98920311A Withdrawn EP1019041A4 (en) 1997-05-07 1998-05-06 Method of improving disturbed behavior and elevating mood in humans

Country Status (6)

Country Link
EP (1) EP1019041A4 (en)
JP (1) JP2002501510A (en)
AU (1) AU743788B2 (en)
CA (1) CA2288693A1 (en)
IL (1) IL132784A (en)
WO (1) WO1998050027A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
EP3955918A1 (en) 2019-04-17 2022-02-23 COMPASS Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427518A1 (en) * 1989-11-07 1991-05-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem NMDA-Blocking compounds, pharmaceutical compositions, their preparation and use
WO1995020958A1 (en) * 1994-02-07 1995-08-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427518A1 (en) * 1989-11-07 1991-05-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem NMDA-Blocking compounds, pharmaceutical compositions, their preparation and use
WO1995020958A1 (en) * 1994-02-07 1995-08-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Study finds Dronabinol promising in Alzheimer disease", JOURNAL OF PHARMACY TECHNOLOGY, CINCINNATI, OH, US, vol. 12, no. 6, November 1996 (1996-11-01), pages 294, XP002114257, ISSN: 8755-1225 *
RUPNIAK ET AL.: "Induction of cognitive impairment by scopolamine and noncholinergic agents in Rhesus monkeys", LIFE SCIENCES, vol. 48, no. 9, 1991, pages 893 - 899, XP008000795 *
See also references of WO9850027A1 *
VOLICER ET AL.: "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease", INT. J. GERIATRIC PSY., vol. 12, no. 9, September 1997 (1997-09-01), pages 913 - 919, XP008000789 *
VOLICER ET AL.: "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease", NEUROBIOLOGY OF AGING, vol. 17, no. 4supl., 1996, pages s73 - s74, XP008000790 *
VOLICER L: "Dronabinol may help behavior problems in Alzheimer's disease", AMERICAN FAMILY PHYSICIAN, AMERICAN ACADEMY OF FAMILY PHYSICIANS, US, vol. 55, no. 4, March 1997 (1997-03-01), pages 1338, XP002114258 *

Also Published As

Publication number Publication date
AU743788B2 (en) 2002-02-07
IL132784A0 (en) 2001-03-19
AU7291698A (en) 1998-11-27
IL132784A (en) 2004-07-25
WO1998050027A1 (en) 1998-11-12
CA2288693A1 (en) 1998-11-12
JP2002501510A (en) 2002-01-15
EP1019041A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
GB9602819D0 (en) Porous-plastic bearing and method of manufacturing porous-plastic bearing
EP0971370A4 (en) Cable and method of manufacturing it
IL138174A0 (en) Electroluminescent device and method of manufacturing same
PL339838A1 (en) Spirally shaped articles and method of making them
GB2322920B (en) Common rail and method of manufacturing the same
GB2322922B (en) Common rail and method of manufacturing the same
EP1019983A4 (en) Connector and method of operation
GB2322921B (en) Common rail and method of manufacturing the same
GB2311192B (en) Data-transmitter-receiver and method of operation
GB9426294D0 (en) High power soperconductive circuits and method of construction thereof
GB9615539D0 (en) Sliding member and method of manufacturing same
GB2336600B (en) Rolling bearing and method of manufacturing the same
HUP0003365A3 (en) Method of manufacturing sertindole and its intermediers
EP1019041A4 (en) Method of improving disturbed behavior and elevating mood in humans
GB2296773B (en) Enzyme electrode and method of manufacturing same
EP1034414A4 (en) Load creation apparatus and method
GB9930276D0 (en) Porous-plastic bearing and method of manufacturing porous-plastic bearing
GB2310318B (en) Ferroelectric component and method of manufacture
GB2324517B (en) Lifting chair and method of lifting
PL322158A1 (en) Method of making formpieces and load-carrying formpiece made thereby
EP0769931A4 (en) An assembly and method for prevention of urinary incontinence in humans
GB9716606D0 (en) Keypad arrangement and method of manufacture thereof
GR2002267Y (en) Grooved section of an electromotor and manufacturing method of said section
EP0696055A3 (en) Electronic assemblies and methods of treatment
EP0907542A4 (en) Slotted component and method of manufacture thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991207

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020305

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20021007

17Q First examination report despatched

Effective date: 20021007

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070519